Liver function drug study halted early
NCT ID NCT05126329
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 33 times
Summary
This study looked at how the drug amcenestrant moves through the body in women aged 40-75 with mild or moderate liver problems, compared to women with healthy livers. The goal was to understand dosing and safety. Only 13 women took part before the study was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC FUNCTION ABNORMAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number :2760001
Kiel, 24105, Germany
-
Investigational Site Number :4100001
Seoul, Seoul-teukbyeolsi, 03080, South Korea
-
Investigational site number :4100002
Cheongju-si, 28644, South Korea
Conditions
Explore the condition pages connected to this study.